&gt; According to Ray Kurzweil, as soon as something becomes an information technology, it starts progressing according to Moore&#x27;s Law<p>My field of chemical information - a subfield of cheminformatics - has been an information technology since the 1800s. It was the Big Data of the 1940s and 1950s, many of the pioneers of information retrieval worked on chemical data (Luhn, Mooers, Taube), and the term &quot;information retrieval&quot; and concepts like stop words (as part of KWIC) were presented at chemistry conferences.<p>The doubling period for chemical information is 15-20 years.<p>Citation indexing is another offshoot of 1950s information technology. Scientific publication grows by about 5% per year (says <a href="http:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC2909426&#x2F;" rel="nofollow">http:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC2909426&#x2F;</a> ), so doubles every 15 years.<p>Either 1) those are not information technology fields, in which case, why not? or 2) &quot;according to Moore&#x27;s Law&quot; means generally &quot;has exponential growth&quot;, not the more specific doubling every two years.<p>With #2 firmly in mind, consider &quot;and that&#x27;s the main reason why we can expect medical technology to advance exponentially in the future.&quot;<p>How do we measure &quot;advance&quot; in medical technology, how do we know it isn&#x27;t already an information technology field, and why should we expect the doubling rate of under 20 years?<p>Finally, here&#x27;s a quote from someone who &quot;served on the advisory council of [a longevity] organization, along with the chairmen of a number of major US corporations&quot;:<p>&gt; Why has the problem of aging been such an intractable one? Up until [recently], the prevalent view of scientists had been that the task of controlling aging was fundamentally impossible. But today, such a consensus no longer exists. Many researchers now believe that their predecessors failed, not because their goals were misguided, but because the tools and the level of sophistication they could bring to the task were inadequate. Moreover, it is argued that progress has been hampered because funding has been scarce, and researchers concerned with aging have been too few and far between. ...<p>&gt; Growing public and private support for aging research reflects the scientific community’s own increasing commitment. Today, aging research occupies unprecedented numbers of highly talented individuals, not only specialists in gerontology, but researchers from other disciplines as well. These include biochemistry, endocrinology, immunology, neurobiology, genetics, and cell biology, to name only a few.<p>Before following the link, when do you think that essay was written? <a href="http:&#x2F;&#x2F;www.garfield.library.upenn.edu&#x2F;essays&#x2F;v6p107y1983.pdf" rel="nofollow">http:&#x2F;&#x2F;www.garfield.library.upenn.edu&#x2F;essays&#x2F;v6p107y1983.pdf</a> .